Roflumilast Attenuates Neuroinflammation and Cognitive Impairment in Intracerbroventricular-Streptozotocin Induced Rat Model of Sporadic Alzheimer’s Disease through Modulation of cAMP/BDNF Signaling Pathway
Journal Title: The 2nd Annual Meeting of International Center for Neuroscience Research - Year 2021, Vol 2, Issue 1
Abstract
Sporadic Alzheimer’s disease (SAD) is the most complex and multifactorial neurodegenerative disease characterized by progressive cognitive deficits and memory loss. Phosphodiesterase (PDE) inhibitors prevent the breakdown of cAMP in the brain, which is an important intracellular secondary messenger for learning and memory functions. Thus, the present study was designed to explore the therapeutic potential of PDE-4 inhibitor roflumilast (RFM) against intracerebroventricular-streptozotocin (ICV-STZ) induced SAD in rats. Subsequently, in vivo study was performed in which rats were infused intracerebroventricularly with two alternate doses of STZ (3 mg/kg bilaterally) proceeding with RFM (0.05 mg/kg orally) treatment for 15 days. Moreover, donepezil, an acetylcholinesterase inhibitor (5 mg/kg orally) was used as a standard drug. Consequently, we observed that RFM significantly improved the ICV-STZ impaired cognitive function in rats as assessed by novel object recognition and Morris Water Maze outcomes. RFM was found to remarkably mitigate the ICV-STZ triggered cholinergic deficits, neuroinflammation, oxidative stress, in rat hippocampus. Supporting these, histopathological analysis using Cresyl violet, and Congo red revealed that RFM attenuated neuronal changes, and Aβ deposition respectively in hippocampus of SAD rats. These outcomes present RFM as an efficient target for the treatment of SAD through activation of cAMP/BDNF signaling pathway.
Authors and Affiliations
Noorul Hasan, Abul Kalam Najmi, Suhel Parvez, Mohd Akhtar*
Keywords
Related Articles
- EP ID EP701741
- DOI -
- Views 88
- Downloads 0
An Early Call to Prevent Valproic Acid Toxicity in the Treatment of Epilepsy
Background: Valproic acid is one of the most prescribed drug for epileptic conditions as it proven to be effective to alleviate epileptic seizures in patients. However, chronic use of this drugs found to produce various...
A Novel Application of CuInS2/Zns Quantum Dot Nanoparticles: Dopamine Detection in Neuronal Synapses
Brain research is the most expanding interdisciplinary research that needs the state of the art technologies to offer advances and opportunities in order to better understanding of human brain while overcoming the chall...
Roflumilast Attenuates Neuroinflammation and Cognitive Impairment in Intracerbroventricular-Streptozotocin Induced Rat Model of Sporadic Alzheimer’s Disease through Modulation of cAMP/BDNF Signaling Pathway
Sporadic Alzheimer’s disease (SAD) is the most complex and multifactorial neurodegenerative disease characterized by progressive cognitive deficits and memory loss. Phosphodiesterase (PDE) inhibitors prevent the breakd...
Brain MRI in Children with Sensorineural Hearing Loss
Introduction: Hearing loss in the first few years of life leads to speech, language and cognitive delays. The most effective method of treating these children is early cochlear implantation. In a significant number of c...
The Beneficial Potential of Human Dental Pulp Stem Cells and their Conditioned Medium in the Treatment of Rat Model of Ischemic Stroke
Dental pulp stem cells (DPSCs) are considered as a promising type of stem cells for cell-based therapies. Hence, in this study we assessed the therapeutic effects of human (h)DPSCs and their conditioned medium (CM) in a...